Who
Scott C. Brun
Director
Company insider
Files Form 4 as: Director, Forte Biosciences; Director, Cabaletta Bio; Director, Jasper Therapeutics.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 24 Jun 2021
- Last trade
- 27 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —31,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,353 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —31,000 | filing |
| 27 Aug 2026filed 27 Aug 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,353 | filing |
| 9 Jun 2026filed 10 Jun 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,353 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | Forte Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,353 at $0.00 | filing |
| 3 Jul 2025filed 3 Jul 2025 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 9 Jun 2025filed 9 Jun 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —44,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —22,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.